Based in All, Genomill is a startup. Brouky records 1 investor associated with the company.
Genomill develops Geno1® library-prep technologies (including Bridge Capture™ and Nicking Loop™) for next-generation sequencing, offering a rapid, ultra-sensitive, PCR-free, and low-cost workflow aimed at diagnostics and targeted sequencing applications such as early cancer detection and MRD monitoring.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.